AMR is threatening human and animal health as well as the environment. The consequences of inaction are too grave to contemplate.
About the MEP Interest Group on AMR
About the AMR Stakeholder Network
Rapid diagnostics in the fight against antimicrobial resistance: ERS and VALUE-Dx project event roundup
Event roundup that gathered over 230 participants, including health professionals, EU officials, patients, researchers, civil society and industry representatives.
MEPs call for a multisectoral and multidisciplinary approach to tackling this silent pandemic.
CSOs signed a joint letter expressing their concern about the list of antimicrobials to be reserved for human health published by the EU Commission.
Bulgarian authorities advise practitioners to not prescribe antibiotics for COVID-19 as a way to fight antibiotic resistance in the broader sense.
10 reasons that make a transferable exclusivity extension a very inefficient and unequal choice for the EU and the world.
The Commission’s proposed regulation to restrict the use of important antimicrobials will have only a very limited impact, and therefore should be amended.
Selected resources produced by the Joint Action on Antimicrobial Resistance and Healthcare-related Infections (EU-JAMRAI)
Investigating the environmental dimensions of AMR: MEP Interest Group on AMR Annual Meeting
17 May 2022
Ensuring responsible antimicrobial use in EU food production: MEP Interest Group on AMR Annual Meeting
29 June 2021
EPHA #A2MDialogues: Sustainable access to effective antibiotics - what should the EU do?
15 April 2021
MEP Interest Group on AMR: 2020 Webinar Series
13,16, 17 November 2020
AMR: setting the agenda for change Official launch of the MEP Interest Group on AMR
19 February 2019
Do you have a question?
Meet our AMR Policy Leads and Scientific Advisors
Rose Gallagher MBE
EPHA Scientific Advisor on AMR
Professional Lead Infection Prevention & Control, Royal College of Nursing (UK)